RU93035028A - A METHOD FOR REDUCING THE BLOOD COVERAGE IN HUMAN - Google Patents

A METHOD FOR REDUCING THE BLOOD COVERAGE IN HUMAN

Info

Publication number
RU93035028A
RU93035028A RU93035028/14A RU93035028A RU93035028A RU 93035028 A RU93035028 A RU 93035028A RU 93035028/14 A RU93035028/14 A RU 93035028/14A RU 93035028 A RU93035028 A RU 93035028A RU 93035028 A RU93035028 A RU 93035028A
Authority
RU
Russia
Prior art keywords
blood
coverage
human
reducing
individualize
Prior art date
Application number
RU93035028/14A
Other languages
Russian (ru)
Inventor
Ю.В. Урываев
Г.А. Петров
Original Assignee
Ю.В. Урываев
Г.А. Петров
Filing date
Publication date
Application filed by Ю.В. Урываев, Г.А. Петров filed Critical Ю.В. Урываев
Publication of RU93035028A publication Critical patent/RU93035028A/en

Links

Claims (1)

Изобретение относится к медицине, а именно - к методам управления свертываемостью крови. С целью снижения дозы вводимого лекарственного вещества, индивидуализации дозировки, исключения побочных реакций и обеспечения возможности многократного применения препарата в течение суток пациенту предлагается при помощи специального приспособления вдыхать пары раствора окситоцина пороговой концентрации, что ведет к снижению свертываемости крови.The invention relates to medicine, namely to the methods of blood coagulation control. In order to reduce the dose of the medicinal substance administered, individualize the dosage, eliminate side reactions and ensure the possibility of repeated use of the drug during the day, the patient is offered to inhale the oxytocin solution threshold concentration using a special device, which leads to a decrease in blood clotting.
RU93035028/14A 1993-07-04 A METHOD FOR REDUCING THE BLOOD COVERAGE IN HUMAN RU93035028A (en)

Publications (1)

Publication Number Publication Date
RU93035028A true RU93035028A (en) 1996-06-10

Family

ID=

Similar Documents

Publication Publication Date Title
ATE292979T1 (en) USE OF ACTIVATED PROTEIN-C TO TREAT EXCESSIVE BLOOD CLOTTING IN SEPSIS
DE69527842T2 (en) LIQUID MEDICINAL PRODUCT CONTAINING ORAL ALENDRONATE
DE69105202D1 (en) SYSTEM FOR THE ADMINISTRATION OF MEDICINES BY A TWO-STAGE IONTOPHORESIS PROCESS.
RU95109905A (en) Liquid, semisolid, solid, gel-like or paste-like compositions and a method of mouth cavity disease treatment
RU95101385A (en) Products containing g-csf and tnf-binding protein
DE3685853D1 (en) AGENTS FOR THE TREATMENT OF BONE DISEASES.
RU93035028A (en) A METHOD FOR REDUCING THE BLOOD COVERAGE IN HUMAN
SU1012923A1 (en) Method of administering medicinal preparations into live organism
RU93043494A (en) METHOD AND DEVICE FOR EXPOSURE TO ULTRAMAL DOSES OF MEDICINES
RU2005430C1 (en) Method for treating osteomyelitis of lower extremities
SE9101341D0 (en) NEW MEDICINAL USE
RU2177303C2 (en) Method for treating orthopedic patients by periarticular drug administration
RU2142271C1 (en) Method of prophylaxis of local and general postischemic complications in long-standing compression injury to extremity
RU2218933C2 (en) Method for sleep normalization
RU2149032C1 (en) Method for applying antioxidation therapy
RU2099061C1 (en) Method for treating the cases of neurodermite
SU1482716A1 (en) Method of treating limb osteomyelitis cases
ATE302944T1 (en) METHOD FOR SCREENING MEDICINAL PREPARATIONS
RU93009359A (en) METHOD OF CORRECTION OF PSYCHOPATHIC BEHAVIOR IN PERSONS OF SCHIZOID WAREHOUSE
RU2152211C1 (en) Method of treatment of patients with eczema
RU2194539C2 (en) Grot method for treating and restoring working ability of patients for general somatic diseases
RU2189812C2 (en) Method for treating the cold trauma
RU2050860C1 (en) Method for treating the cases of mainly proliferative changes in joints
KR920700041A (en) Therapeutic Compounds and Their Composition and Uses
RU2002129102A (en) TREATMENT OF SEPARATE DOSES OF AGENTS WITH VASCULAR DESTRUCTIVE ACTIVITY